Management of inflammatory bowel disease beyond tumor necrosis factor inhibitors: novel biologics and small-molecule drugs
Soo-Young Na, You Sun Kim
Korean J Intern Med. 2022;37(5):906-919. Published online 2022 Aug 10 DOI: https://doi.org/10.3904/kjim.2022.152
Citations to this article as recorded by 
Saudi consensus guidance for the diagnosis and management of inflammatory bowel disease in children and adolescents
Omar I. Saadah, Turki AlAmeel, Ahmed Al Sarkhy, Mohammed Hasosah, Abdulrahman Al-Hussaini, Majid A. Almadi, Badr Al-Bawardy, Talal A. Altuwaijri, Mohammed AlEdreesi, Shakir A. Bakkari, Othman R. Alharbi, Nahla A. Azzam, Abdulelah Almutairdi, Khalidah A. A
Saudi Journal of Gastroenterology.2025; 31(3): 107. CrossRef
Gentianopsis paludosa Regulates TL1A/DR3 and ZNF281 to Affect Inflammatory Bowel Disease-Associated Intestinal Fibrosis
Zhao Huiqiao, Lu Nianhua, Zhang Yongpeng, Jin Guoyin, He Wei
International Journal of Pharmacology.2024; 20(4): 642. CrossRef
Dopamine β-hydroxylase shapes intestinal inflammation through modulating T cell activation
Qiaoling Sun, Heng Li, Jing Lv, Weilin Shi, Yanfeng Bai, Ke Pan, Alice Chen
Cellular Immunology.2024; 401-402: 104839. CrossRef
Meta-analysis of etrolizumab versus placebo in ulcerative colitis: safety and efficacy outcomes
Rui Zhang, Ziran Jia, Yingshi Piao
Therapeutic Advances in Gastroenterology.2024;[Epub] CrossRef
Cellular Plasticity in Gut and Liver Regeneration
Minwook Kim, Yoojeong Park, You Sun Kim, Sungjin Ko
Gut and Liver.2024; 18(6): 949. CrossRef
Treatment of primary sclerosing cholangitis combined with inflammatory bowel disease
You Sun Kim, Edward H. Hurley, Yoojeong Park, Sungjin Ko
Intestinal Research.2023; 21(4): 420. CrossRef